Target Name: ZNF267
NCBI ID: G10308
Review Report on ZNF267 Target / Biomarker Content of Review Report on ZNF267 Target / Biomarker
ZNF267
Other Name(s): ZN267_HUMAN | zinc finger protein 2 | zinc finger protein 267 | zinc finger protein HZF2 | Zinc finger protein 2 | zinc finger (C2H2) | Zinc finger protein HZF2 | Zinc finger (C2H2) | Zinc finger protein 267 | HZF2

ZNF267: A Potential Drug Target and Biomarker for Diseases

ZNF267 (ZN267_HUMAN), a gene that encodes for a protein known as ZNF267, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. ZNF267 is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression and has been shown to be involved in the development and progression of various diseases.

The ZNF267 gene was first identified in 2005 using computational tools such as RNA-Seq and gene expression arrays. The gene encodes for a protein that is composed of 214 amino acids and has been shown to play a role in the regulation of gene expression in various organisms, including humans. ZNF267 has been shown to be involved in the regulation of cell adhesion, cell signaling, and cell cycle progression, among other processes.

One of the most promising aspects of ZNF267 is its potential as a drug target. ZNF267 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. For example, studies have shown that high levels of ZNF267 expression are associated with poor prognosis in patients with colorectal cancer, and that blocking the activity of ZNF267 has been shown to be effective in treating this form of cancer.

In addition to its potential as a drug target, ZNF267 has also been shown to be a potential biomarker for various diseases. For example, studies have shown that ZNF267 levels are elevated in the brains of patients with Alzheimer's disease, and that blocking the activity of ZNF267 has been shown to be effective in treating this form of dementia. Additionally, ZNF267 has been shown to be involved in the regulation of gene expression in various psychiatric disorders, including depression and schizophrenia.

The discovery of ZNF267 has also led to a greater understanding of its role in the regulation of gene expression and the development and progression of various diseases. ZNF267 has been shown to play a role in the regulation of cell adhesion, cell signaling, and cell cycle progression, among other processes. It has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

In conclusion, ZNF267 is a gene that has the potential to be a drug target and biomarker for various diseases. Its role in the regulation of gene expression and its association with the development and progression of various diseases make it an attractive target for research and development of new treatments. Further studies are needed to fully understand the role of ZNF267 in the regulation of gene expression and its potential as a drug target and biomarker.

Protein Name: Zinc Finger Protein 267

Functions: May be involved in transcriptional regulation

The "ZNF267 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF267 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414